BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 20129431)

  • 1. Chronic hepatitis C--assessment in civil law: a case study.
    Santos BM; Sousa P; Mena F; Costa GS; Corte-Real F; Vieira DN
    J Forensic Leg Med; 2010 Feb; 17(2):99-101. PubMed ID: 20129431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosis of hepatitis C virus-infected Canadian post-transfusion compensation claimant cohort.
    Thein HH; Yi Q; Heathcote EJ; Krahn MD
    J Viral Hepat; 2009 Nov; 16(11):802-13. PubMed ID: 19413692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expert's opinion in civil proceedings for damages in cases relating to hospital infections, especially to hepatitis B and C infections].
    Chowaniec C
    Arch Med Sadowej Kryminol; 2005; 55(4):251-6. PubMed ID: 16498962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon treatment of chronic hepatitis C in patients cured of pediatric malignancies.
    Cesaro S; Bortolotti F; Petris MG; Brugiolo A; Cusinato R; Guido M; Rossetti F; Masiero L; Zanesco L
    Haematologica; 2000 Jan; 85(1):63-6. PubMed ID: 10629594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An investigation of the psychosocial impact of a Compensation Tribunal on women with latrogenic hepatitis C infection.
    Coughlan B; Sheehan J; Carr A; Crowe J
    Ir Med J; 2003 Mar; 96(3):73-7. PubMed ID: 12722782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of aging on the development of hepatocellular carcinoma in patients with posttransfusion chronic hepatitis C.
    Hamada H; Yatsuhashi H; Yano K; Daikoku M; Arisawa K; Inoue O; Koga M; Nakata K; Eguchi K; Yano M
    Cancer; 2002 Jul; 95(2):331-9. PubMed ID: 12124834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The management of acute hepatitis C and needlestick accidents with hepatitis-C virus positive blood].
    Cooreman MP; Weegink C; Reesink HW
    Ned Tijdschr Geneeskd; 1998 Oct; 142(42):2298-300. PubMed ID: 9864524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating the prognosis of hepatitis C patients infected by transfusion in Canada between 1986 and 1990.
    Krahn M; Wong JB; Heathcote J; Scully L; Seeff L
    Med Decis Making; 2004; 24(1):20-9. PubMed ID: 15005951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Look-back study of Hepatitis C in teenagers after blood transfusions as neonates.
    Kori M; Flidel-Rimon O; Sigler E; Shinwell E; Granot E
    Acta Paediatr; 2007 Jul; 96(7):1050-2. PubMed ID: 17498189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus infection-related Type 1 diabetes mellitus.
    Chen LK; Chou YC; Tsai ST; Hwang SJ; Lee SD
    Diabet Med; 2005 Mar; 22(3):340-3. PubMed ID: 15717885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The long term outcome of thirty eight post-transfusion hepatitis C.
    Punyagupta S; Siwadune T
    J Med Assoc Thai; 2001 Jan; 84(1):12-8. PubMed ID: 11281489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is legal medicine--are legal and forensic medicine the same?
    Beran RG
    J Forensic Leg Med; 2010 Apr; 17(3):137-9. PubMed ID: 20211453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study.
    Seeff LB; Hollinger FB; Alter HJ; Wright EC; Cain CM; Buskell ZJ; Ishak KG; Iber FL; Toro D; Samanta A; Koretz RL; Perrillo RP; Goodman ZD; Knodell RG; Gitnick G; Morgan TR; Schiff ER; Lasky S; Stevens C; Vlahcevic RZ; Weinshel E; Tanwandee T; Lin HJ; Barbosa L
    Hepatology; 2001 Feb; 33(2):455-63. PubMed ID: 11172349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient threatens legal action over lack of compensation for hepatitis C contaminated blood.
    Dyer C
    BMJ; 2016 Sep; 354():i4937. PubMed ID: 27634623
    [No Abstract]   [Full Text] [Related]  

  • 15. Health care-associated hepatitis B and C viruses: legal aspects.
    Bobinski MA
    Clin Liver Dis; 2010 Feb; 14(1):105-17; ix. PubMed ID: 20123444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superinfection by homotypic virus in hepatitis C virus carriers: studies on patients with post-transfusion hepatitis.
    Kao JH; Chen PJ; Wang JT; Yang PM; Lai MY; Wang TH; Chen DS
    J Med Virol; 1996 Dec; 50(4):303-8. PubMed ID: 8950686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
    Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ
    Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combined antiviral treatment in a patient with recurrent chronic hepatitis C after liver transplantation].
    Csák T; Folhoffer A; Horváth A; Lengyel G; Kóbori L; Szalay F
    Orv Hetil; 2004 Sep; 145(39):2003-6. PubMed ID: 15553912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Legal, financial, and public health consequences of transfusion-transmitted hepatitis C virus in persons with haemophilia.
    Angelotta C; McKoy JM; Fisher MJ; Buffie CG; Barfi K; Ramsey G; Frohlich L; Bennett CL
    Vox Sang; 2007 Aug; 93(2):159-65. PubMed ID: 17683360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinico-epidemiology of hepatitis C viral infection in northeastern Thailand.
    Chunlertrith K; Sukeepaisarnjaroen W; Mairiang P; Urwijitaroon Y; Takase K; Yamauchi T; Yoshimura H; Tameda Y
    Southeast Asian J Trop Med Public Health; 2000 Jun; 31(2):273-6. PubMed ID: 11127325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.